featured
news articles

Total number of categories

Total number of articles

Market/Novel Tech

Drug companies sued in multiple States over price-fixing of generic drugs, several leading up to 1,000% increase of cost to patients

Global news reports have highlighted a lawsuit in 44 states in the US for price-fixing and collusion among several large pharmaceutical companies.  Following for the shares fell for Teva, Mylan, Novartis, Sandoz, Pfizer and others.  Over 100 pharmaceutical products linked to the lawsuit includes drugs such as lamivudine-zidovudine for H.I.V. treatment; budesonide for asthma; fenofibrate […]

Read full story
Featured

A Cochrane systematic review identifies pars plana vitrectomy vs scleral buckling repair for rhegmatogenous retinal detachments

A Cochrane comprehensive study has confirmed that there is a low, or very low, certainty evidence indicating that “there may be little or no difference between PPV (pars plana vitrectomy) and scleral buckling in terms of primary success rate, visual acuity gain and final anatomical success in treating primary RRD (rhegmatogenous retinal detachment)”.  The Cochrane […]

Read full story
Research

A comprehensive study of the retina in Alzheimer’s disease reports a marked thinning of inner and outer retinal nerve fibre layers

Researchers in the Doheny Eye Institute in Los Angeles, US, have published a study on marked pathological tissues in the retinal nerve fibre layers (RNFL) with Alzheimer’s disease (AD).  While several previous studies have reported on OCT research from AD patients in the retina, the current reports indicate that clinical utility of the retina as […]

Read full story
Introduction

May 16th, 2019: “EURETINA-Brief”© Issue No. 192

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the May 15th, 2019 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”.  EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story
Research

Five-year outcomes of retinal vein occlusion provide long term data for anti-VEGF treatments on real-world data

Researchers at the Sydney Institute of Vision Science, in New South Wales, Australia report that good long-term efficacy of anti-VEGF therapy over 5 years provides a real-world setting, albeit different to the outcome data reported from clinical trial publications. In follow-up to real-world 5-year outcome data on a retrospective population, the results indicate that a […]

Read full story
Introduction

April 16th, 2019: “EURETINA-Brief” Issue No. 190

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the April 16th, 2019 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”.  EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story

Latest News

Book Review